Long-term complete remission inbladder carcinoma in situ with intravesical tice bacillus Calmette guerin: Overview analysis of six phase II clinical trials
- 作者R. De Jager; E. Guinan; D. Lamm; O. Khanna; S. Brosman; J. De Kernion; R. Williams; C. Richardson; L. Muenz; D. Reitsma; M.G. Hanna JR.
- 卷第38卷
- 期第6期
- 文件大小891.71KB
- 发表时间1991
- DOI10.1016/0090-4295(91)80166-5
- 页码507-513
Malignancies in Bladder Augmentations and Intestinal ConduitsFilmer, R. Bruce; Spencer, Julia R. · The Journal of Urology · 1990
Metastatic renal tumor presenting as ovarian clear cell carcinomaJulia R. Spencer; Brenda Eriksen; John E. Garnett · 1993
Poor resource quality lowers transmission potential by changing foraging behaviourPenczykowski, Rachel M.; Lemanski, Brian C. P.; Sieg, R. Drew; Hall, Spencer R.; Housley Ochs, Jessica; Kubanek, Julia; Duffy, Meghan A.; Hõrak, Peeter · Functional Ecology · 2014
Design and Synthesis of Selective Keto-1,2,4-oxadiazole-based Tryptase Inhibitors.James T. Palmer; Robert M. Rydzewski; Rohan V. Mendonca; David Sperandio; Jeffrey R. Spencer; Bernard L. Hirschbein; Julia Lohmann; Jeri Beltman; Margaret Nguyen; Liang Liu · 2006
Design and synthesis of selective keto-1,2,4-oxadiazole-based tryptase inhibitorsJames T. Palmer; Robert M. Rydzewski; Rohan V. Mendonca; David Sperandio; Jeffrey R. Spencer; Bernard L. Hirschbein; Julia Lohman; Jeri Beltman; Margaret Nguyen; Liang Liu · 2006
Tolerance to temperature and water quality for bacterial oxidation: The benefits of BacTech's moderately thermophilic cultureJulia R. Budden; Peter A. Spencer · 1993
Novel, potent, selective, and orally bioavailable human βII-tryptase inhibitorsDavid Sperandio; Vincent W.-F. Tai; Julia Lohman; Bernie Hirschbein; Rohan Mendonca; Chang-Sun Lee; Jeffrey R. Spencer; James Janc; Margaret Nguyen; Jerlyn Beltman; Paul Sprengeler; Heleen Scheerens; Tong Lin; Liang Liu; Ashwini Gadre; Alisha Kellogg; Michael J. Green; Mary E. McGrath · 2006